“foresite-capital” Archives

in
Entry Author Date Location
Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies 08/26/20 San Francisco
Olema Adds $54M to Start Human Tests of Breast Cancer Drug Candidate 07/22/20 San Francisco
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development 05/26/20 San Francisco
Bio Roundup: Alnylam’s Billions, COVID-19 Vaccines, Moma Debuts & More 04/17/20 National
Cerevance Raises $45M to Advance Brain Disease Research & Development 04/14/20 Boston
Keros Outlines IPO Plans Amid Markets Rocked by Coronavirus Pandemic 03/23/20 Boston
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans 01/13/20 Boston
Element Biosciences Lands $15M to Develop New Genetic Analysis Tools 06/19/19 San Diego
Turning Point Prices IPO, Raising $166M to Test Cancer Drugs 04/17/19 San Diego
Insitro Lands Three-Year Deal With Gilead to Find New NASH Drugs 04/16/19 National
Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs 03/22/19 San Diego
Relay Raises $400M to Kick Protein Motion Drug R&D into High Gear 12/20/18 Boston
Working with Patients and a Fresh $80M, Fulcrum Eyes a 2019 IPO 09/05/18 Boston
Alector Snags $133M to Activate Immune Cells Against Neurodegeneration 07/25/18 San Francisco
Decibel Hauls in $55M to Bring Multiple Hearing Drugs to the Clinic 06/19/18 Boston
Mindstrong Adds $15M for Tech That Predicts Mental Health Changes 06/14/18 San Francisco
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
Tempest Therapeutics Debuts with $70M to Bring Cancer Drugs to Clinic 03/28/18 San Francisco
Fresh Off $25M Raise, Generation Adds $100M For Next-Gen Gene Therapy 02/27/18 Boston
After Strong 2017, Biotechs & Medtechs Start ’18 with Venture, IPO News 01/02/18 National
Next Stop on Father’s Duchenne Quest: Wall Street? Solid Raises $50M 03/30/17 Boston
10X Genomics Lands $55,000,000 Series C Funding Round 03/17/16 San Francisco
Twist Bioscience Garners $61,000,000 Series D Financing 01/19/16 San Francisco
ORIC Pharmaceuticals Receives $53,000,000 Series B Round 12/03/15 San Francisco
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
Audentes Therapeutics Garners $65,000,000 Series C Funding 10/14/15 San Francisco
AveXis Obtains $65,000,000 Series D Round 09/09/15 Texas
At Summer’s End, Can Crossover Winds Stay At Biotech’s Back? 09/01/15 National
Intellia Therapeutics Receives $70,000,000 Series B Financing Round 09/01/15 Boston
Page 1 of 2 next page »